TTK Healthcare Limited (BOM:507747)
India · Delayed Price · Currency is INR 951.10
-0.90 (-0.09%)
At close: Feb 12, 2026
TTK Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 8,297 | 8,015 | 7,528 | 7,251 | 5,992 | 4,761 | |
Revenue Growth (YoY) | 4.73% | 6.47% | 3.82% | 21.00% | 25.87% | -26.28% |
Cost of Revenue | 4,065 | 3,907 | 3,560 | 3,630 | 2,912 | 2,193 |
Gross Profit | 4,231 | 4,108 | 3,968 | 3,621 | 3,080 | 2,568 |
Selling, General & Admin | 2,678 | 2,582 | 2,488 | 2,268 | 1,952 | 1,657 |
Other Operating Expenses | 1,277 | 1,174 | 1,100 | 1,034 | 907.86 | 714.85 |
Operating Expenses | 4,047 | 3,843 | 3,724 | 3,435 | 2,988 | 2,504 |
Operating Income | 183.93 | 265.27 | 244.22 | 186.81 | 92.82 | 64.36 |
Interest Expense | -18.21 | -19.49 | -19.29 | -52.39 | -32.38 | -17.11 |
Interest & Investment Income | 695.15 | 695.15 | 622.17 | 463.7 | 147.59 | 98.78 |
Currency Exchange Gain (Loss) | 2.11 | 2.11 | 2.57 | 5.62 | 3.12 | 0.29 |
Other Non Operating Income (Expenses) | 19.69 | 1.54 | -6.94 | 14 | 12.6 | 0.28 |
EBT Excluding Unusual Items | 882.68 | 944.57 | 842.73 | 617.74 | 223.75 | 146.6 |
Gain (Loss) on Sale of Assets | -0.31 | -0.31 | -0.33 | -1.38 | -0.16 | -1.19 |
Asset Writedown | -0.01 | -0.01 | -1.2 | - | -0.13 | -0.17 |
Other Unusual Items | -134.43 | 139.07 | - | - | 24.91 | 80.98 |
Pretax Income | 747.94 | 1,083 | 841.2 | 616.36 | 248.37 | 226.22 |
Income Tax Expense | 147.27 | 266.75 | 212.78 | 169.68 | 63.27 | -141.6 |
Earnings From Continuing Operations | 600.67 | 816.57 | 628.42 | 446.68 | 185.1 | 367.82 |
Earnings From Discontinued Operations | - | - | - | 5,950 | 230.78 | 96.59 |
Net Income | 600.67 | 816.57 | 628.42 | 6,397 | 415.88 | 464.41 |
Net Income to Common | 600.67 | 816.57 | 628.42 | 6,397 | 415.88 | 464.41 |
Net Income Growth | -28.31% | 29.94% | -90.18% | 1438.20% | -10.45% | 276.98% |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 |
Shares Change (YoY) | 0.01% | - | - | - | - | - |
EPS (Basic) | 42.51 | 57.79 | 44.47 | 452.73 | 29.43 | 32.87 |
EPS (Diluted) | 42.51 | 57.79 | 44.47 | 452.73 | 29.43 | 32.87 |
EPS Growth | -28.30% | 29.95% | -90.18% | 1438.20% | -10.45% | 276.96% |
Free Cash Flow | - | -168.16 | -153.27 | -365.1 | 394.91 | 946.88 |
Free Cash Flow Per Share | - | -11.90 | -10.85 | -25.84 | 27.95 | 67.01 |
Dividend Per Share | - | 10.000 | 10.000 | 10.000 | 10.000 | 6.000 |
Dividend Growth | - | - | - | - | 66.67% | 100.00% |
Gross Margin | 51.00% | 51.26% | 52.71% | 49.94% | 51.40% | 53.94% |
Operating Margin | 2.22% | 3.31% | 3.24% | 2.58% | 1.55% | 1.35% |
Profit Margin | 7.24% | 10.19% | 8.35% | 88.22% | 6.94% | 9.75% |
Free Cash Flow Margin | - | -2.10% | -2.04% | -5.04% | 6.59% | 19.89% |
EBITDA | 225.54 | 341.73 | 367.16 | 314.38 | 217.99 | 193.72 |
EBITDA Margin | 2.72% | 4.26% | 4.88% | 4.34% | 3.64% | 4.07% |
D&A For EBITDA | 41.61 | 76.47 | 122.95 | 127.57 | 125.16 | 129.36 |
EBIT | 183.93 | 265.27 | 244.22 | 186.81 | 92.82 | 64.36 |
EBIT Margin | 2.22% | 3.31% | 3.24% | 2.58% | 1.55% | 1.35% |
Effective Tax Rate | 19.69% | 24.62% | 25.30% | 27.53% | 25.47% | - |
Revenue as Reported | 9,027 | 8,727 | 8,154 | 7,734 | 6,156 | 4,860 |
Advertising Expenses | - | 1,048 | 1,132 | 1,012 | 893.1 | 698.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.